How Doxazosin Helps Kill Prostate Cancer Cells
Author Information
Author(s): Partin J V, Anglin I E, Kyprianou N
Primary Institution: University of Kentucky Medical Center
Hypothesis
This study aimed to identify the molecular mechanism underlying the apoptotic action of quinazoline-based α1-adrenoceptor antagonists against prostate cancer cells.
Conclusion
Doxazosin induces apoptosis in prostate cancer cells through the activation of the TGF-β1 signaling pathway and the involvement of NF-κB nuclear effectors.
Supporting Evidence
- Doxazosin was shown to activate caspase-3, confirming its apoptotic effect.
- The study found that doxazosin treatment led to increased expression of TGF-β1 and IκBα.
- Microarray analysis revealed significant changes in gene expression related to apoptosis after doxazosin treatment.
Takeaway
Doxazosin, a medication usually for high blood pressure, can help kill prostate cancer cells by making them die in a way that is similar to how normal cells would when they stop getting certain hormones.
Methodology
The study used cell culture, cDNA microarray analysis, RT-PCR, Western blot analysis, and ELISA to investigate the effects of doxazosin on prostate cancer cells.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website